Filing Details
IDEXX LABORATORIES INC /DE (NASDAQ:IDXX) filed a Form 8-K with the Securities and Exchange Commission on November 02, 2026, disclosing a material event.
8k filedNASDAQ:IDXX
IDEXX LABORATORIES INC /DE (IDXX) Reports Material Event to SEC
IDEXX LABORATORIES INC /DE (NASDAQ:IDXX) filed a Form 8-K with the Securities and Exchange Commission on November 02, 2026, disclosing a material event.
At publication ·
What changed
IDEXX LABORATORIES INC /DE (NASDAQ:IDXX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- IDEXX Laboratories filed a Form 8-K with the SEC on November 2, 2026, disclosing a material event that shareholders should know about.
- The company's stock trades at $551.21 with a market capitalization of $56.5 billion as of the filing date.
- Material events reported on Form 8-K can include leadership changes, acquisitions, asset sales, or changes to financial guidance.
Market Context
IDEXX LABORATORIES INC /DE's stock currently trades at $551.21 with a market capitalization of $56.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for IDEXX LABORATORIES INC /DE's stock.
All SEC filings for IDEXX LABORATORIES INC /DE are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IDXX Stock Page
Frequently Asked Questions
Where can I read IDXX's SEC filings?
Browse all filings on our IDXX SEC filings page.
What types of SEC filings does IDEXX LABORATORIES INC /DE file?
Public companies like IDEXX LABORATORIES INC /DE file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
